We noticed that various channels shared information about the legal proceedings between BioConnection B.V. and Prestige Biologics Co. Limited: On 11 March 2025, the Dutch court ruled in favor of BioConnection in an inspection procedure against Prestige Biologics.
We hereby refer to the original text of the Court ruling and its English language machine translation.
About BioConnection
BioConnection (BCO) is a specialized contract manufacturing organization (specialized CMO) serving the pharmaceutical industry. Operating from our FDA and EMA-certified facility in Oss, North Brabant, we specialize in producing injectable (bio)pharmaceutical products. Our services cover Chemistry, Manufacturing, and Controls (CMC), including drug product manufacturing process development, Fill & Finish for liquid, and freeze-drying (lyophilization) in vials and syringes. We also provide specialized small-scale (hand fill) production for personalized medicines, ensuring precision and flexibility.
At BioConnection, we support the entire drug life cycle, from producing materials for toxicology studies to clinical material manufacturing (Phase I-III) and final market production (up to 500 L). We excel in seamless project transitions, including internal technical transfers, scale-ups, and efficient preparation for Process Performance Qualification (PPQ) campaigns before market launch.
Ultimately, BioConnection drives healthcare innovation through strategic collaborations and emerging trend partnerships. While we do not engage in pharmacovigilance, our drug products are manufactured to meet strict quality standards that support this crucial aspect of the drug life cycle. We are committed to global health initiatives and sustainable manufacturing practices, improving access to life-saving medicines worldwide. Therefore, we would be delighted to discuss how we can support your projects.
